In this study, we showed that combined IRE and anti-PD1 immune checkpoint blockade significantly suppressed tumor growth and prolonged the lives of immunocompetent mice bearing well-established orthotopic PDAC or melanoma tumors. Here, PDCD1 is linked to neoplasm.